Literature DB >> 29992402

[Normal tissue: radiosensitivity, toxicity, consequences for planning].

A Rühle1,2, P E Huber3,4.   

Abstract

Along with chemotherapy, surgery and immunotherapy, radiotherapy is a mainstay of cancer treatment. Considering the improving survival rates for various malignancies during the past decades, the importance of radiation-induced late normal tissue response is increasing. Quality of life is becoming an important issue in modern cancer treatment and is correlated with acute and late normal tissue response after radiotherapy. A profound understanding of radiation-induced normal tissue response is necessary to sufficiently diagnose and treat radiation-induced side effects and thereby increase the patients' quality of life. Here, the various normal tissue responses in consideration of the radiation biology are specified and prospective options to attenuate radiation-induced side effects are discussed.

Entities:  

Keywords:  Ionizing radiation; Quality of life; Radiotherapy; Side effects; Tumors

Mesh:

Year:  2018        PMID: 29992402     DOI: 10.1007/s00117-018-0430-4

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  60 in total

1.  Management of acoustic neuromas with fractionated stereotactic radiotherapy (FSRT): long-term results in 106 patients treated in a single institution.

Authors:  Stephanie E Combs; Sigrid Volk; Daniela Schulz-Ertner; Peter E Huber; Christoph Thilmann; Jürgen Debus
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-09-01       Impact factor: 7.038

2.  New insights for pelvic radiation disease treatment: Multipotent stromal cell is a promise mainstay treatment for the restoration of abdominopelvic severe chronic damages induced by radiotherapy.

Authors:  Alain Chapel; Sabine Francois; Luc Douay; Marc Benderitter; Jan Voswinkel
Journal:  World J Stem Cells       Date:  2013-10-26       Impact factor: 5.326

3.  Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine.

Authors:  Marc W Münter; Simone Hoffner; Holger Hof; Klaus K Herfarth; Uwe Haberkorn; Volker Rudat; Peter Huber; Jürgen Debus; Christian P Karger
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-12-15       Impact factor: 7.038

4.  Osteoradionecrosis of the mandible: pathogenesis.

Authors:  J Bras; H K de Jonge; J P van Merkesteyn
Journal:  Am J Otolaryngol       Date:  1990 Jul-Aug       Impact factor: 1.808

5.  Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors.

Authors:  Raymond Miralbell; Antony Lomax; Laura Cella; Uwe Schneider
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-11-01       Impact factor: 7.038

6.  Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy.

Authors:  B S Henson; M R Inglehart; A Eisbruch; J A Ship
Journal:  Oral Oncol       Date:  2001-01       Impact factor: 5.337

Review 7.  Radiation-induced second cancers: the impact of 3D-CRT and IMRT.

Authors:  Eric J Hall; Cheng-Shie Wuu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-05-01       Impact factor: 7.038

8.  The Radiation Resistance of Human Multipotent Mesenchymal Stromal Cells Is Independent of Their Tissue of Origin.

Authors:  Alexander Rühle; Oliver Xia; Ramon Lopez Perez; Thuy Trinh; Wiltrud Richter; Anna Sarnowska; Patrick Wuchter; Jürgen Debus; Rainer Saffrich; Peter E Huber; Nils H Nicolay
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-01-09       Impact factor: 7.038

9.  In vivo measurement of dose distribution in patients' lymphocytes: helical tomotherapy versus step-and-shoot IMRT in prostate cancer.

Authors:  Felix Zwicker; Benedict Swartman; Falk Roeder; Florian Sterzing; Henrik Hauswald; Christian Thieke; Klaus-Josef Weber; Peter E Huber; Kai Schubert; Jürgen Debus; Klaus Herfarth
Journal:  J Radiat Res       Date:  2014-10-31       Impact factor: 2.724

Review 10.  Intensity modulated radiotherapy (IMRT) in the treatment of children and adolescents--a single institution's experience and a review of the literature.

Authors:  Florian Sterzing; Eva M Stoiber; Simeon Nill; Harald Bauer; Peter Huber; Jürgen Debus; Marc W Münter
Journal:  Radiat Oncol       Date:  2009-09-23       Impact factor: 3.481

View more
  4 in total

Review 1.  The Therapeutic Potential of Mesenchymal Stromal Cells in the Treatment of Chemotherapy-Induced Tissue Damage.

Authors:  Alexander Rühle; Ramon Lopez Perez; Bingwen Zou; Anca-Ligia Grosu; Peter E Huber; Nils H Nicolay
Journal:  Stem Cell Rev Rep       Date:  2019-06       Impact factor: 5.739

Review 2.  Radiotherapy-induced heart disease: a review of the literature.

Authors:  Bingwen Zou; Julius Philipp Schuster; Kerun Niu; Qianyi Huang; Alexander Rühle; Peter Ernst Huber
Journal:  Precis Clin Med       Date:  2019-11-29

Review 3.  Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy.

Authors:  Simone de Leve; Florian Wirsdörfer; Verena Jendrossek
Journal:  Front Immunol       Date:  2019-04-05       Impact factor: 7.561

4.  Assessment of Normal Tissue Radiosensitivity by Evaluating DNA Damage and Repair Kinetics in Human Brain Organoids.

Authors:  Jovana Bojcevski; Changwen Wang; Haikun Liu; Amir Abdollahi; Ivana Dokic
Journal:  Int J Mol Sci       Date:  2021-12-07       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.